{
    "Trade/Device Name(s)": [
        "ImmunoCAP Allergen f338, Scallop",
        "ImmunoCAP Specific IgE"
    ],
    "Submitter Information": "Phadia US Inc.",
    "510(k) Number": "k071913",
    "Predicate Device Reference 510(k) Number(s)": [
        "k051218"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "August 24, 2007",
    "Summary Letter Received Date": "July 11, 2007",
    "Submission Date": "July 2, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RST) Immunological Test System"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "Allergen specific IgE",
        "Scallop specific IgE"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP Instrument System",
        "ImmunoCAP 100",
        "ImmunoCAP 250",
        "ImmunoCAP 1000"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Allergen f338, Scallop assay for quantifying scallop-specific IgE antibodies using ImmunoCAP systems.",
    "Indications for Use Summary": "In vitro quantitative assay for measurement of allergen specific IgE in human serum or plasma, aiding diagnosis of IgE mediated allergic disorders, for use with ImmunoCAP systems in clinical and physician office laboratories.",
    "fda_folder": "Immunology"
}